Literature DB >> 28644704

Numerical analysis of time dependent inhibition kinetics: comparison between rat liver microsomes and rat hepatocyte data for mechanistic model fitting.

Chuong Pham1, Swati Nagar1, Ken Korzekwa1.   

Abstract

Time dependent inhibition (TDI) may confound drug interaction predictions. Recently, models were generated for an array of TDI kinetic schemes using numerical analysis of microsomal assays. Additionally, a distinct terminal inactivation step was identified for certain mechanism based inhibitors (MBI) following reversible metabolite intermediate complex (MIC) formation. Longer hepatocyte incubations potentially allow analysis of slow TDI and terminal inactivation. In the experiments presented here, we compared the quality of TDI parameterization by numerical analysis between hepatocyte and microsomal data. Rat liver microsomes (RLM), suspended rat hepatocytes (SRH), and sandwich-cultured rat hepatocytes (SCRH) were incubated with the prototypical CYP3A MBI troleandomycin and the substrate midazolam. Data from RLM provided a better model fit as compared to SRH. Increased CYP3A expression after dexamethasone (DEX) induction improved the fit for RLM and SRH. A novel sequential kinetic scheme, defining inhibitor metabolite production prior to MIC formation, improved the fit compared to direct MIC formation. Furthermore, terminal inactivation rate constants were parameterized for RLM and SRH samples with DEX induced CYP3A. The low expression of CYP3A and experimental error in SCRH resulted in poor data for model fitting. Overall, RLM generated data better suited for elucidation of TDI mechanisms by numerical analysis.

Entities:  

Keywords:  Cytochrome P450; Hepatocytes; Mechanism Based Inhibition; Microsomes; Time Dependent Inhibition

Year:  2017        PMID: 28644704      PMCID: PMC5742070          DOI: 10.1080/00498254.2017.1345020

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  44 in total

1.  Evaluation of time-dependent inactivation of CYP3A in cryopreserved human hepatocytes.

Authors:  Ping Zhao; Kent L Kunze; Caroline A Lee
Journal:  Drug Metab Dispos       Date:  2005-03-02       Impact factor: 3.922

2.  Identification of cytochrome P450 3A4 modification site with reactive metabolite using linear ion trap-Fourier transform mass spectrometry.

Authors:  Hideo Yukinaga; Tomonori Takami; Sho-Hei Shioyama; Zenzaburo Tozuka; Hiroshi Masumoto; Osamu Okazaki; Ken-Ichi Sudo
Journal:  Chem Res Toxicol       Date:  2007-09-15       Impact factor: 3.739

3.  Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.

Authors:  Yoshiki Matsuda; Yoshihiro Konno; Masahiro Satsukawa; Taro Kobayashi; Yu Takimoto; Kunihiko Morisaki; Shinji Yamashita
Journal:  Drug Metab Dispos       Date:  2012-08-28       Impact factor: 3.922

4.  Mechanism-based enzyme inactivators.

Authors:  R B Silverman
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil.

Authors:  Ying-Hong Wang; David R Jones; Stephen D Hall
Journal:  Drug Metab Dispos       Date:  2005-02-02       Impact factor: 3.922

6.  Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.

Authors:  Dermot F McGinnity; Amanda J Berry; Jane R Kenny; Ken Grime; Robert J Riley
Journal:  Drug Metab Dispos       Date:  2006-05-05       Impact factor: 3.922

7.  Problems in using isolated and cultured hepatocytes for xenobiotic metabolism/metabolism-based toxicity testing-Solutions?

Authors:  P Skett
Journal:  Toxicol In Vitro       Date:  1994-06       Impact factor: 3.500

8.  CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.

Authors:  Ping Kang; Mingxiang Liao; Michael R Wester; J Steven Leeder; Robin E Pearce; Maria Almira Correia
Journal:  Drug Metab Dispos       Date:  2007-12-20       Impact factor: 3.922

9.  Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid.

Authors:  M P López-Garcia; P M Dansette; D Mansuy
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

10.  Bioactivation of the cancer chemopreventive agent tamoxifen to quinone methides by cytochrome P4502B6 and identification of the modified residue on the apoprotein.

Authors:  Chitra Sridar; Jaime D'Agostino; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2012-08-31       Impact factor: 3.922

View more
  4 in total

1.  Impact of Lipid Partitioning on the Design, Analysis, and Interpretation of Microsomal Time-Dependent Inactivation.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2019-05-01       Impact factor: 3.922

2.  Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.

Authors:  Ilia G Denisov; Yelena V Grinkova; Mark A McLean; Tyler Camp; Stephen G Sligar
Journal:  Biomolecules       Date:  2022-06-20

3.  Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Mol Pharm       Date:  2018-04-10       Impact factor: 4.939

Review 4.  Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

Authors:  Jaydeep Yadav; Erickson Paragas; Ken Korzekwa; Swati Nagar
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.